Alibaba
BABA
Broadcom
AVGO
Netflix
NFLX
Tesla
TSLA
Meta Platforms
META
US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 8.210
- -0.380-4.42%
Trading Mar 11 10:31 ET
875.43MMarket Cap-3.01P/E (TTM)
8.660High8.160Low312.73KVolume8.540Open8.590Pre Close2.63MTurnover0.36%Turnover RatioLossP/E (Static)106.63MShares28.67052wk High1.89P/B708.05MFloat Cap8.16052wk Low--Dividend TTM86.24MShs Float67.480Historical High--Div YieldTTM5.82%Amplitude7.565Historical Low8.399Avg Price1Lot Size
Rocket Pharmaceuticals News
Rocket Pharmaceuticals Price Target Cut to $36.00/Share From $39.00 by Canaccord Genuity
Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $36
Promising Pipeline and Financial Stability Drive Buy Rating for Rocket Pharmaceuticals
When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit?
LifeSci Capital Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $55
Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)
A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $15 to $42
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
Morgan Stanley Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)
A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $32 to $42
Rocket Pharmaceuticals Is Maintained at Buy by Needham
Rocket Pharmaceuticals Analyst Ratings
Promising Pipeline and Market Opportunities Drive Buy Rating for Rocket Pharmaceuticals
Express News | Rocket Pharmaceuticals Inc : Needham Cuts Target Price to $42 From $52
Rocket Pharmaceuticals Executive Makes Significant Stock Sale
Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Janux Therapeutics Inc (JANX)
8-K: Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
Rocket Pharmaceuticals Q4 2024 GAAP EPS $(0.62) Beats $(0.71) Estimate
Express News | Rocket Pharmaceuticals: Expects Cash Resources Sufficient to Fund Operations Into Q3 2026
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.